Skip to Main Content

Paper Details

Global Risk Indicator and Therapy for Older Patients With Diffuse Large B-Cell Lymphoma: A Population-Based Study.
JCO Oncol Pract
2
2022
Diffuse Large B-Cell Lymphoma, Patients, diffuse large B-cell lymphoma, patient, patients
Author NameAffiliation
Orestis A PanagiotouMongan Institute, Center for Aging and Serious Illness, Massachusetts General Hospital
Orestis A PanagiotouDepartment of Health Services, Brown University School of Public Health
Orestis A PanagiotouCenter for Evidence Synthesis in Health, Brown University School of Public Health
Orestis A PanagiotouMongan Institute, Center for Aging and Serious Illness, Massachusetts General Hospital
Orestis A PanagiotouDepartment of Health Services, Brown University School of Public Health
Orestis A PanagiotouCenter for Evidence Synthesis in Health, Brown University School of Public Health
  • 1 - 6

Datasets